Pure Global

GLYSO-EYE Sodium Hyaluronate 0.1% w/v Ophthalmic Solution - FDA Registration CMDR-2023-01704

Access comprehensive regulatory information for GLYSO-EYE Sodium Hyaluronate 0.1% w/v Ophthalmic Solution in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2023-01704 and manufactured by Highkon Pharma - S-2, Manish Metro Plaza, Plot No. 2 MLU, Pocket-5 Sector-12, Dwarka, New Delhi- 110075, India Mfd. By: Maya Biotech Pvt. LTd. - Village Kondi, P.O. Thana Baddi, The Nalagarh, Distt. Solan - 173205 Hitmachal Pradesh India in India. The device was registered on June 22, 2023.

This page provides complete registration details including manufacturer information, importer/distributor details (Ambica International Corporation), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
India
CMDR-2023-01704
GLYSO-EYE Sodium Hyaluronate 0.1% w/v Ophthalmic Solution
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
GLYSO-EYE Sodium Hyaluronate 0.1% w/v Ophthalmic Solution
Registration Number
CMDR-2023-01704
Importer & Distribution
Registration Dates
Issuance Date
June 22, 2023
Expiry Date
June 22, 2028